Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, holds an MSc. in Virology and Immunology and has worked on research on multiple sclerosis during the course of her graduate studies.

October 9, 2018October 9, 2018

EMD Serono, ACP Work Jointly to Make MS Clinical Trials More Patient-focused

News

The Accelerated Cure Project (ACP) for Multiple Sclerosis and EMD Serono— a unit of Merck KGaA —  will jointly incorporate the perspectives of U.S. and Canadian multiple sclerosis (MS) patients into the design ... Read more

September 25, 2018October 2, 2018

Dalfampridine ER Tablets, Generic Version of Ampyra, Now Available in US, Mylan Announces

News

Mylan announced its U.S. launch of dalfampridine extended-release (ER) tablets, the authorized generic version of Acorda‘s Ampyra, that work to improve walking abilities in adults with multiple sclerosis (MS). Both ... Read more

September 10, 2018September 10, 2018

MS in Child Considerably Affects Quality of Life for Family, Study Reports

News

Parents of children with pediatric-onset multiple sclerosis (MS) report a lower overall quality of life than those whose kids have a condition marked by demyelination but is not a chronic disease, ... Read more

August 31, 2018August 31, 2018

A&W Canada ‘Burgers to Beat MS’ Campaign Raises $1.9 Million

News

A&W Food Services of Canada, a chain of hamburger restaurants, in partnership with the Multiple Sclerosis Society of Canada, raised more than $1.9 million at its 10th annual “Burgers to Beat ... Read more

August 21, 2018August 22, 2018

Consecutive Use of Gilenya and Lemtrada Causes Disease Activity in MS Patient, Case Report Suggests

News

Multiple sclerosis (MS) patients may experience severe disease exacerbation after switching from Novartis’ Gilenya (fingolimod) to Sanofi Genzyme’s Lemtrada (alemtuzumab), a case report suggests. This unexpected high disease activity raises questions about managing ... Read more

May 16, 2018May 25, 2018

Complications from Gilenya Treatment Managed Successfully, Case Report Says

News

A case study reported the successful management of a multiple sclerosis (MS) patient who developed a rare condition in the brain — progressive multifocal leukoencephalopathy (PML) — due to treatment with ... Read more

May 3, 2018May 3, 2018

Past, Present and Possible Future Directions of MS Research Topic of Educational Talk

News

The science underlying our understanding of multiple sclerosis — through to new technologies that might expand that understanding in ways “never imagined” — was the focus of a recent educational webinar titled ... Read more

March 12, 2018March 12, 2018

High Sun Exposure During Childhood May Lower Risk of MS, Study Finds

News

People who live in areas with medium to high levels of ultraviolet-B (UV-B) radiation from sunlight during their childhood and early adolescence, or in the years preceding the age of ... Read more

December 12, 2017December 14, 2017

Using Balloons to Increase Blood Flow from Brain Fails to Help MS Patients, Trial Finds

News

Using balloons to enlarge veins so that more blood flows out of the brain and spinal cord fails to help multiple sclerosis patients, according to a clinical trial in Italy. ... Read more

November 30, 2017December 5, 2017

Health Costs Higher, But Outcomes Better for MS Patients Who Take Their Meds, Study Finds

News

Multiple sclerosis patients who adhere strictly to their medication pay more but stay healthier in the long run than those who don’t, a study found. Researchers at Liberty University College of Osteopathic ... Read more

November 3, 2017November 3, 2017

RedHill Awaits US Patent for Antibiotic Combo, RHB-104, as Potential RRMS Therapy

News

RedHill Biopharma has received a Notice of Allowance for a new patent on RHB-104 its potential therapy for patients with relapsing-remitting multiple sclerosis (RRMS). Once granted by the United States Patent and Trademark Office ... Read more

November 2, 2017November 13, 2017

Myelin-producing Brain Cells Regenerated Using Stem Cells in Early Study

News

Researchers, using two different kinds of stem cells in rats, were able to regenerate oligodendrocytes — myelin-producing brain cells that are defective in multiple sclerosis (MS). They were also able ... Read more

September 6, 2017September 6, 2017

Older Women with MS Age Better Than Their Male Counterparts, Canadian Survey Finds

News

Older men with multiple sclerosis (MS) have more harmful lifestyles than older women with the disease, concludes the Canadian Survey of Health, Lifestyle and Aging with Multiple Sclerosis. Treatment for depression could ... Read more

August 31, 2017August 31, 2017

MS and a Type of Schizophrenia May Belong to the Same Class of Disorders, Review Concludes

News

Striking similarities between patients with multiple sclerosis and a type of schizophrenia suggest the disorders are related, according to a review of a number of studies. Dr. Boris M. Arneth wrote ... Read more

August 15, 2017August 16, 2017

Most Patients Prefer Betaconnect Autoinjector for MS Treatment, German Survey Shows

News

A patient satisfaction evaluation of three autoinjector devices for delivering multiple sclerosis treatments found that Bayer’s electronic autoinjector Betaconnect was the choice of 57 percent of the 85 people who ... Read more

July 19, 2017July 20, 2017

Costs Associated with Multiple Sclerosis Rise as Severity of Disease Increases, European Study Shows

News

Costs associated with multiple sclerosis increase as the disease worsens, according to a study of more than 16,000 patients in 16 European countries. The study, “New insights into the burden and ... Read more

July 17, 2017July 18, 2017

Combined High-Intensity Interval, Resistance Training Improves Physical Health and Quality of Life in MS

News

In a pilot study with patients with multiple sclerosis, high-intensity interval training combined with resistance training improved physical capacity and quality of life in a pilot study of multiple sclerosis ... Read more

July 12, 2017July 13, 2017

Allergy Medicine Fails to Reduce Flu-Like Syndrome in Relapsing-remitting MS Patients, Study Shows

News

According to a new clinical trial, the allergy treatment cetirizine fails to alleviate a flu-like condition that interferon-beta treatment generates in people with relapsing-remitting multiple sclerosis. The results, which surprised researchers, ... Read more

July 6, 2017July 6, 2017

Lipoic Acid, an Over-the-counter Antioxidant, Seen to Slow Brain Atrophy in SPMS Patients

News

The over-the-counter antioxidant lipoic acid slowed brain deterioration in patients with secondary progressive multiple sclerosis (SPMS), according to a pilot study. An Oregon Health & Science University research team conducted the ... Read more

June 23, 2017May 21, 2018

Genentech to Report on Ocrevus Success in Reducing Disease Progression in Relapsing and Primary Progressive MS at EAN Congress

News, Ocrevus

Ocrevus (ocrelizumab) significantly reduces disease activity and disability progression in patients with relapsing multiple sclerosis (MS) and primary progressive MS (PPMS), according to results of post-hoc analyses of Genentech’s Phase 3 clinical ... Read more

June 23, 2017June 26, 2017

Tecfidera Improves MS Patients’ Work Productivity, Compared with Other Therapies, Study Shows

News

Multiple sclerosis patients taking Tecfidera, or dimethyl fumarate, were more productive at work than those on Copaxone or beta-interferon therapies, according to a study. Tecfidera also increased patients’ quality of ... Read more

June 15, 2017June 15, 2017

High Salt Consumption Has No Effect on Multiple Sclerosis Symptoms or Prognosis, Study Finds

News

Eating a diet high in salt won’t worsen or speed up multiple sclerosis (MS) symptoms, concludes a study of MS patients with clinically isolated syndrome (CIS). That contradicts earlier studies by ... Read more

May 1, 2017May 1, 2017

Canadian Parliamentarians Helping Kick Off MS Awareness Month

News

Members of Parliament are helping the Multiple Sclerosis Society of Canada commemorate May as MS Awareness Month. The lawmakers will be meeting with society representatives and other members of the MS community in ... Read more

April 24, 2017April 24, 2017

Glove with Sensors Measures Spasticity More Accurately than Physicians

News

A  multidisciplinary team at the University of California at San Diego has come up with a computerized glove used as a sensor to measure spasticity, or stiffness, in the limbs ... Read more

January 27, 2017January 27, 2017

Sense of Smell Is Impaired in Half of Multiple Sclerosis Patients in Study

News

Many multiple sclerosis (MS) patients have a reduced sense of smell, and the more relapses they have, the worse the problem, according to a study suggesting that smell may be ... Read more

January 9, 2017January 9, 2017

Paleolithic Diet Improved RRMS Patients’ Quality of Life, Study Shows

News

A modified Paleolithic diet reduced fatigue and increased the quality of life of patients with relapsing-remitting multiple sclerosis (RRMS), a study shows. The diet may also reduce inflammation by increasing ... Read more